Related Experiment Video
Updated: Jun 20, 2026
08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Anionic nucleotide--lipids for in vitro DNA transfection
Salim Khiati1, Nathalie Pierre, Soahary Andriamanarivo
1INSERM U869, Bordeaux, F-33076, France.
Bioconjugate Chemistry
|August 29, 2009
Summary
New anionic nucleotide-based lipids enhance nucleic acid delivery in vitro. These novel lipids show improved transfection efficacy and low toxicity, offering a promising alternative to traditional cationic reagents.
Area of Science:
- Biochemistry
- Materials Science
- Nanotechnology
Background:
- Nucleic acid delivery is crucial for gene therapy and research.
- Current transfection reagents, often cationic, can exhibit toxicity.
- Development of safe and effective anionic delivery systems is needed.
Purpose of the Study:
- To synthesize and characterize novel anionic nucleotide-based lipids.
- To evaluate their efficacy in nucleic acid (DNA) delivery in vitro.
- To investigate the structural basis for enhanced transfection and assess cytotoxicity.
Main Methods:
- Synthesis of nucleotide lipids from 1,2-diacyl-sn-glycerols and 2'-deoxythymidine-3'-phosphoramidite.
- Gel electrophoresis to assess lipid-DNA complex formation in the presence of Ca(2+).
- Transfection experiments on Hek cell lines.
- Small-angle X-ray scattering (SAXS) to study lipid phase behavior.
- MTS assay for cytotoxicity evaluation.
Main Results:
- Nucleotide-lipid-DNA complexes formed at Ca(2+) concentrations > 1 mM.
- Enhanced transfection efficacy compared to natural anionic lipids (DPPA, DPPG).
- SAXS revealed a 2D columnar inverted hexagonal phase (H(II)) in nucleotide lipid formulations, correlating with transfection enhancement.
- Palmitoyl nucleotide derivative complexes showed no significant toxicity to Hek cells after 4h incubation.
Conclusions:
- Anionic nucleotide-based lipids are effective for in vitro nucleic acid delivery.
- The nucleotide moiety and specific lipid phase (H(II)) contribute to improved transfection.
- These novel anionic lipids represent a non-toxic alternative to cationic transfection reagents.
